Kubota A, Lian R H, Lohwasser S, Salcedo M, Takei F
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, Canada.
J Immunol. 1999 Dec 15;163(12):6488-93.
Activation of NK cells by target cells leads to cytotoxicity as well as production of various cytokines including IFN-gamma. MHC class I molecules on target cells regulate NK cytotoxicity. However, little is known about the regulation of IFN-gamma production by NK cells. We examined the production of IFN-gamma in individual murine NK cells stimulated with tumor cell lines by flow cytometric analysis of intracellular IFN-gamma. Among several tumor lines tested, the rat basophilic leukemia line RBL-1 induced particularly high level of IFN-gamma production in IL-2-activated NK cells, whereas other lines, including the prototypic NK target YAC-1, induced very low or no IFN-gamma production. Transfection of murine classical MHC class I molecules into RBL-1 cells substantially inhibited IFN-gamma production. This inhibition of IFN-gamma production by MHC class I was independent of Ly-49 or CD94/NKG2A expression on NK cells. These results indicate that some target cells directly stimulate IL-2-activated NK cells and induce IFN-gamma production, but the requirements for the induction of IFN-gamma production seem different from those for NK cytotoxicity. Furthermore, similar to NK cytotoxicity, induction of IFN-gamma production is inhibited by MHC class I on stimulating cells. However, the MHC class I-specific receptors inhibiting IFN-gamma production are different from those for NK cytotoxicity.
靶细胞激活自然杀伤细胞(NK细胞)会导致细胞毒性以及包括γ干扰素(IFN-γ)在内的多种细胞因子的产生。靶细胞上的主要组织相容性复合体(MHC)I类分子调节NK细胞的细胞毒性。然而,关于NK细胞对IFN-γ产生的调节知之甚少。我们通过对细胞内IFN-γ进行流式细胞术分析,检测了用肿瘤细胞系刺激的单个小鼠NK细胞中IFN-γ的产生情况。在所测试的几种肿瘤细胞系中,大鼠嗜碱性白血病细胞系RBL-1在白细胞介素-2(IL-2)激活的NK细胞中诱导产生特别高水平的IFN-γ,而其他细胞系,包括典型的NK靶细胞YAC-1,诱导产生的IFN-γ非常低或不产生。将小鼠经典MHC I类分子转染到RBL-1细胞中可显著抑制IFN-γ的产生。MHC I类分子对IFN-γ产生的这种抑制作用与NK细胞上Ly-49或CD94/NKG2A的表达无关。这些结果表明,一些靶细胞直接刺激IL-2激活的NK细胞并诱导IFN-γ的产生,但诱导IFN-γ产生的条件似乎与NK细胞毒性的条件不同。此外,与NK细胞毒性类似,刺激细胞上的MHC I类分子可抑制IFN-γ的产生。然而,抑制IFN-γ产生的MHC I类特异性受体与NK细胞毒性的受体不同。